Reviews: Current topics role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review)

Journal of Nutritional Biochemistry

Volumn 14, Issue 10, 2003, Pages 554-567

  Khan, Seher A ^a   Vanden Heuvel, John P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Fatty acid; Gene; Nuclear receptor; Transcription

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ANTILIPEMIC AGENT; ARACHIDONIC ACID; CELL NUCLEUS RECEPTOR; CIGLITAZONE; EPOXYICOSATRIENOIC ACID; FATTY ACID; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEPATOCYTE NUCLEAR FACTOR 4; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHYTANIC ACID; PIRINIXIC ACID; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ZINC FINGER PROTEIN; CELL RECEPTOR; LIGAND;

ADIPOSE TISSUE; ADRENAL GLAND; AMINO TERMINAL SEQUENCE; ATHEROSCLEROSIS; BLOOD CLOTTING; BRAIN MATURATION; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CORONARY ARTERY DISEASE; DETOXIFICATION; DIABETES MELLITUS; DNA BINDING; ENDOCRINE DISEASE; ENDOCRINOLOGY; FAT INTAKE; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HEMATOPOIESIS; HORMONE BINDING; HUMAN; HYPERINSULINEMIA; INTESTINE; KIDNEY; LIPID METABOLISM; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PEROXISOME; PHYSIOLOGY; REPRODUCTION; REVIEW; SKELETAL MUSCLE; THERMOGENESIS; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECT; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; DIETARY FATS; FATTY ACIDS; GENE EXPRESSION REGULATION; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0141992044     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(03)00098-6     Document Type: Review

References (142)

1. De Caterina R., Zampolli A. n-3 fatty acids antiatherosclerotic effects . Lipids. 36:2001;S69-78.
2. Abeywardena M.Y., Head R.J. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res. 52:2001;361-371.
3. Abeywardena M.Y., Head R.J. Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat. Prostaglandins Leukot Essent Fatty Acids. 65:2001;91-97.
4. Welsch C.W. Dietary fat, calories, and mammary gland tumorigenesis. Adv Exp Med Biol. 322:1992;203-222.
5. Welsch C.W. Relationship between dietary fat and experimental mammary tumorigenesis a review and critique . Cancer Res. 52:1992;2040s-2048s.
6. Reddy B.S. Dietary fat and colon cancer animal model studies . Lipids. 27:1992;807-813.
7. Chin J.P. Marine oils and cardiovascular reactivity. Prostaglandins Leukot Essent Fatty Acids. 50:1994;211-222.
8. Houseknecht K.L., Vanden Heuvel J.P., Moya-Camarena S.Y., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 244:1998;678-682.
9. Belury M.A., Nickel K.P., Bird C.E., Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer. 26:1996;149-157.
10. Ip C., Chin S.F., Scimeca J.A., Pariza M.W. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 51:1991;6118-6124.
11. Yang H., Glickman B.W., de Boer J.G. Effect of conjugated linoleic acid on the formation of spontaneous and PhIP-induced mutation in the colon and cecum of rats. Mutat Res. 500:2002;157-168.
12. Lee K.N., Kritchevsky D., Pariza M.W. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 108:1994;19-25.
13. Beato M. Transcriptional control by nuclear receptors. Faseb J. 5:1991;2044-2051.
14. Collingwood T.N., Urnov F.D., Wolffe A.P. Nuclear receptors coactivators, corepressors and chromatin remodeling in the control of transcription . J Mol Endocrinol, 23:1999;255-275.
15. A unified nomenclature system for the nuclear receptor superfamily. Cell. 97:1999;161-163.
16. Di Croce L., Okret S., Kersten S., et al. Steroid and nuclear receptors. Villefranche-sur-Mer, France, May 25-27, 1999. Embo J. 18:1999;6201-6210.
17. Egea P.F., Klaholz B.P., Moras D. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett. 476:2000;62-67.
18. Escriva H., Langlois M.C., Mendonca R.L., Pierce R., Laudet V. Evolution and diversification of the nuclear receptor superfamily. Ann N Y Acad Sci. 839:1998;143-146.
19. Freedman LP. Strategies for transcriptional activation by steroid/ nuclear receptors. J Cell Biochem 1999;Suppl:103-9.
20. Horwitz K.B., Jackson T.A., Bain D.L., Richer J.K., Takimoto G.S., Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 10:1996;1167-1177.
21. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors shifting endocrinology into reverse . Science. 284:1999;757-760.
22. Laudet V. Evolution of the nuclear receptor superfamily early diversification from an ancestral orphan receptor . J Mol Endocrinol. 19:1997;207-226.
23. Manteuffel-Cymborowska M. Nuclear receptors, their coactivators and modulation of transcription. Acta Biochim Pol. 46:1999;77-89.
24. Schwabe J.W. Transcriptional control how nuclear receptors get turned on . Curr Biol. 6:1996;372-374.
25. Sladek R., Giguere V. Orphan nuclear receptors an emerging family of metabolic regulators . Adv Pharmacol. 47:2000;23-87.
26. Tenbaum S., Baniahmad A. Nuclear receptors structure, function and involvement in disease . Int J Biochem Cell Biol. 29:1997;1325-1341.
27. Wahli W., Martinez E. Superfamily of steroid nuclear receptors positive and negative regulators of gene expression . Faseb J. 5:1991;2243-2249.
28. Waxman D.J. P450 gene induction by structurally diverse xenochemicals central role of nuclear receptors CAR, PXR, and PPAR . Arch Biochem Biophys. 369:1999;11-23.
29. Escher P., Wahli W. Peroxisome proliferator-activated receptors insight into multiple cellular functions . Mutat Res. 448:2000;121-138.
30. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 63:1994;451-486.
31. McDonnell D.P., Vegeto E., Gleeson M.A. Nuclear hormone receptors as targets for new drug discovery. Biotechnology (N Y). 11:1993;1256-1261.
32. Huang Q., Alvares K., Chu R., Bradfield C.A., Reddy J.K. Association of peroxisome proliferator-activated receptor and Hsp72. J Biol Chem. 269:1994;8493-8497.
33. Sumanasekera W.K., Tien E.S., Turpey R., Vanden Heuvel J.P., Perdew G.H. Evidence that PPARalpha is complexed with the 90 kDa heat shock protein and the hepatitis virus B X-associated protein 2. J Biol Chem. 13:2002;13.
34. Weatherman R.V., Fletterick R.J., Scanlan T.S. Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem. 68:1999;559-581.
35. Maalouf G.J., Xu W., Smith T.F., Mohr S.C. Homology model for the ligand-binding domain of the human estrogen receptor. J Biomol Struct Dyn. 15:1998;841-851.
36. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
37. Blumberg B., Evans R.M. Orphan nuclear receptors-new ligands and new possibilities. Genes Dev. 12:1998;3149-3155.
38. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
39. Gottlicher M., Widmark E., Li Q., Gustafsson J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 89:1992;4653-4657.
40. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
41. Sher T., Yi H.F., McBride O.W., Gonzalez F.J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32:1993;5598-5604.
42. Lemberger T., Braissant O., Juge-Aubry C., et al. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann N Y Acad Sci. 804:1996;231-251.
43. Peters J.M., Hennuyer N., Staels B., et al. Alterations in lipoprotein metabolism in peroxisome proliferator- activated receptor alpha-deficient mice. J Biol Chem. 272:1997;27307-27312.
44. Ricote M., Huang J.T., Welch J.S., Glass C.K. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol. 66:1999;733-739.
45. Willson T.M., Brown P.J., Sternbach D.D., Henke B.R. The PPARs from orphan receptors to drug discovery . J Med Chem. 43:2000;527-550.
46. Cowart L.A., Wei S., Hsu M.H., et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem. 277:2002;35105-35112.
47. Yu K., Bayona W., Kallen C.B., et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem. 270:1995;23975-23983.
48. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 384:1996;39-43.
49. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 400:1999;378-382.
50. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:1995;803-812.
51. Kozak K.R., Gupta R.A., Moody J.S., et al. 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J Biol Chem. 277:2002;23278-23286.
52. Xu H.E., Lambert M.H., Montana V.G., et al. Molecular recognition of fatty acids by peroxisome proliferator- activated receptors. Mol Cell. 3:1999;397-403.
53. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
54. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature, 358:1992;771-774.
55. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. Embo J. 11:1992;433-439.
56. Zhang B., Marcus S.L., Miyata K.S., Subramani S., Capone J.P., Rachubinski R.A. Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J Biol Chem. 268:1993;12939-12945.
57. Issemann I., Prince R., Tugwood J., Green S. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem Soc Trans. 20:1992;824-827.
58. Muerhoff A.S., Griffin K.J., Johnson E.F. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J Biol Chem. 267:1992;19051-19053.
59. Juge-Aubry C., Pernin A., Favez T., et al. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J Biol Chem. 272:1997;25252-25259.
60. Jpenberg I.A., Jeannin E., Wahli W., Desvergne B. Polarity and specific sequence requirements of peroxisome proliferator- activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J Biol Chem. 272:1997;20108-20117.
61. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Embo J. 15:1996;5336-5348.
62. Nishiyama C., Hi R., Osada S., Osumi T. Functional interactions between nuclear receptors recognizing a common sequence element, the direct repeat motif spaced by one nucleotide (DR- 1). J Biochem (Tokyo). 123:1998;1174-1179.
63. Miyata K.S., Zhang B., Marcus S.L., Capone J.P., Rachubinski R.A. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling. J Biol Chem. 268:1993;19169-19172.
64. Marcus S.L., Capone J.P., Rachubinski R.A. Identification of COUP-TFII as a peroxisome proliferator response element binding factor using genetic selection in yeast COUP-TFII activates transcription in yeast but antagonizes PPAR signaling in mammalian cells . Mol Cell Endocrinol. 120:1996;31-39.
65. Nakshatri H., Bhat-Nakshatri P. Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res. 26:1998;2491-2499.
66. Winrow C.J., Capone J.P., Rachubinski R.A. Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene. J Biol Chem. 273:1998;31442-31448.
67. Yan Z.H., Karam W.G., Staudinger J.L., Medvedev A., Ghanayem B.I., Jetten A.M. Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4. J Biol Chem. 273:1998;10948-10957.
68. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405:2000;421-424.
69. Rocchi S., Auwerx J. Peroxisome proliferator-activated receptor-gamma a versatile metabolic regulator . Ann Med. 31:1999;342-351.
70. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPAR gamma 2 tissue-specific regulator of an adipocyte enhancer . Genes Dev. 8:1994;1224-1234.
71. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
72. Zhang B., Berger J., Hu E., et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol. 10:1996;1457-1466.
73. Kubota N., Terauchi Y., Miki H., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 4:1999;597-609.
74. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 272:1997;3406-3410.
75. Tontonoz P., Singer S., Forman B.M., et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A. 94:1997;237-241.
76. Sarraf P., Mueller E., Jones D., et al. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med. 4:1998;1046-1052.
77. Takashima T., Fujiwara Y., Higuchi K., et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int J Oncol. 19:2001;465-471.
78. He T.C., Chan T.A., Vogelstein B., Kinzler K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell, 99:1999;335-345.
79. Willy P.J., Mangelsdorf D.J. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11:1997;289-298.
80. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 16:2000;459-481.
81. Apfel R., Benbrook D., Lernhardt E., Ortiz M.A., Salbert G., Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol. 14:1994;7025-7035.
82. Song C., Kokontis J.M., Hiipakka R.A., Liao S. Ubiquitous receptor a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors . Proc Natl Acad Sci U S A. 91:1994;10809-10813.
83. Tobin K.A., Ulven S.M., Schuster G.U., et al. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem. 277:2002;10691-10697.
84. Yoshikawa T., Shimano H., Yahagi N., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem. 277:2002;1705-1711.
85. Miyata K.S., McCaw S.E., Patel H.V., Rachubinski R.A., Capone J.P. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J Biol Chem. 271:1996;9189-9192.
86. Laffitte B.A., Repa J.J., Joseph S.B., et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A. 98:2001;507-512.
87. Jump D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol. 13:2002;155-164.
88. Ou J., Tu H., Shan B., et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand- dependent activation of the LXR. Proc Natl Acad Sci U S A. 98:2001;6027-6032.
89. Wang L., Schuster G.U., Hultenby K., Zhang Q., Andersson S., Gustafsson J.A. Liver X receptors in the central nervous system from lipid homeostasis to neuronal degeneration . Proc Natl Acad Sci U S A. 99:2002;13878-13883.
90. Cao G., Liang Y., Broderick C.L., et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem. 31:2002;31.
91. Muscat G.E., Wagner B.L., Hou J., et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J Biol Chem. 277:2002;40722-40728.
92. Tangirala R.K., Bischoff E.D., Joseph S.B., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A. 99:2002;11896-11901.
93. Chawla A., Boisvert W.A., Lee C.H., et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 7:2001;161-171.
94. Peet D.J., Turley S.D., Ma W., et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell. 93:1998;693-704.
95. Alberti S., Schuster G., Parini P., et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest. 107:2001;565-573.
96. Jiang G., Nepomuceno L., Hopkins K., Sladek F.M. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol. 15:1995;5131-5143.
97. Sladek, FM. Liver Gene Expression. Landers Co., 1994.
98. Hertz R., Magenheim J., Berman I., Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature. 392:1998;512-516.
99. Jump D.B., Clarke S.D. Regulation of gene expression by dietary fat. Annu Rev Nutr. 19:1999;63-90.
100. Petrescu A.D., Hertz R., Bar-Tana J., Schroeder F., Kier A.B. Ligand specificity and conformational dependence of the hepatic nuclear factor-4alpha (HNF-4alpha). J Biol Chem. 277:2002;23988-23999.
101. Rajas F., Gautier A., Bady I., Montano S., Mithieux G. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6- phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha. J Biol Chem. 277:2002;15736-15744.
102. Wang H., Maechler P., Antinozzi P.A., Hagenfeldt K.A., Wollheim C.B. Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem. 275:2000;35953-35959.
103. Bartoov-Shifman R., Hertz R., Wang H., Wollheim C.B., Bar-Tana J., Walker M.D. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. J Biol Chem. 277:2002;25914-25919.
104. Marrapodi M., Chiang J.Y. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Lipid Res. 41:2000;514-520.
105. Patel D.D., Knight B.L., Soutar A.K., Gibbons G.F., Wade D.P. The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene. Biochem J. 351:2000;747-753. Pt. 3.
106. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., Gonzalez F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 21:2001;1393-1403.
107. Inoue Y., Hayhurst G.P., Inoue J., Mori M., Gonzalez F.J. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha). HNF4alpha regulates ornithine transcarbamylase in vivo. J Biol Chem, 277:2002;25257-25265.
108. Mangelsdorf D.J., Borgmeyer U., Heyman R.A., et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6:1992;329-344.
109. Dolle P., Fraulob V., Kastner P., Chambon P. Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev. 45:1994;91-104.
110. Sugawara A., Yen P.M., Qi Y., Lechan R.M., Chin W.W. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology. 136:1995;1766-1774.
111. Liu Q., Linney E. The mouse retinoid-X receptor-gamma gene genomic organization and evidence for functional isoforms . Mol Endocrinol. 7:1993;651-658.
112. de Urquiza A.M., Liu S., Sjoberg M., et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 290:2000;2140-2144.
113. Madsen L., Dyroy E., Berge R. EPA and DHA possess different metabolic properties. Adv Exp Med Biol. 466:1999;315-320.
114. Lemotte P.K., Keidel S., Apfel C.M. Phytanic acid is a retinoid X receptor ligand. Eur J Biochem. 236:1996;328-333.
115. Schluter A., Yubero P., Iglesias R., Giralt M., Villarroya F. The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation. Int J Obes Relat Metab Disord. 26:2002;1277-1280.
116. Claudel T., Leibowitz M.D., Fievet C., et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A. 98:2001;2610-2615.
117. Mukherjee R., Davies P.J., Crombie D.L., et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386:1997;407-410.
118. Macchia P.E., Jiang P., Yuan Y.D., et al. RXR receptor agonist suppression of thyroid function central effects in the absence of thyroid hormone receptor . Am J Physiol Endocrinol Metab. 283:2002;E326-331.
119. Kastner P., Grondona J.M., Mark M., et al. Genetic analysis of RXR alpha developmental function convergence of RXR and RAR signaling pathways in heart and eye morphogenesis . Cell. 78:1994;987-1003.
120. Mascrez B., Mark M., Krezel W., et al. Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. Development. 128:2001;2049-2062.
121. Li M., Indra A.K., Warot X., et al. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature. 407:2000;633-636.
122. Ip C., Scimeca J.A., Thompson H.J. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer. 74:1994;1050-1054.
123. Belury M.A., Vanden Heuvel J.P. Protection against cancer and heart disease by the dietary fat, conjugated linoleic acid potential mechanisms of action . Nutr Disease Update Journal. 1:1997;58-63.
124. Belury, MA, Vanden Heuvel, JP. Conjugated linoleic acid and diabetes. In: Pariza M, ed. Conjugated Linoleic Acid: American Chemical Society 1999.
125. Park Y., Albright K.J., Liu W., Storkson J.M., Cook M.E., Pariza M.W. Effect of conjugated linoleic acid on body composition in mice. Lipids. 32:1997;853-858.
126. Precht D., Molkentin J. Effect of feeding on conjugated cis delta 9, trans delta 11- octadecadienoic acid and other isomers of linoleic acid in bovine milk fats. Nahrung. 41:1997;330-335.
127. Sehat N., Kramer J.K., Mossoba M.M., et al. Identification of conjugated linoleic acid isomers in cheese by gas chromatography, silver ion high performance liquid chromatography and mass spectral reconstructed ion profiles. Comparison of chromatographic elution sequences. Lipids. 33:1998;963-971.
128. Kramer J.K., Sehat N., Dugan M.E., et al. Distributions of conjugated linoleic acid (CLA) isomers in tissue lipid classes of pigs fed a commercial CLA mixture determined by gas chromatography and silver ion-high-performance liquid chromatography. Lipids. 33:1998;549-558.
129. Ip C., Lisk D.J., Scimeca J.A. Potential of food modification in cancer prevention. Cancer Res. 54:1994;1957s-1959s.
130. Jiang J., Bjorck L., Fonden R. Production of conjugated linoleic acid by dairy starter cultures. J Appl Microbiol. 85:1998;95-102.
131. Szebeni J., Eskelson C., Sampliner R., et al. Plasma fatty acid pattern including diene-conjugated linoleic acid in ethanol users and patients with ethanol-related liver disease. Alcohol Clin Exp Res. 10:1986;647-650.
132. Banni S., Carta G., Angioni E., et al. Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. J Lipid Res. 42:2001;1056-1061.
133. Truitt A., McNeill G., Vanderhoek J.Y. Antiplatelet effects of conjugated linoleic acid isomers. Biochim Biophys Acta. 1438:1999;239-246.
134. Park Y., Storkson J.M., Albright K.J., Liu W., Pariza M.W. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 34:1999;235-241.
135. Ip C., Dong Y., Thompson H.J., Bauman D.E., Ip M.M. Control of rat mammary epithelium proliferation by conjugated linoleic acid. Nutr Cancer. 39:2001;233-238.
136. Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res. 40:1999;1426-1433.
137. Peters J.M., Park Y., Gonzalez F.J., Pariza M.W. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha- null mice. Biochim Biophys Acta. 1533:2001;233-242.
138. Moya-Camarena S.Y., Vanden Heuvel J.P., Belury M.A. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta. 1436:1999;331-342.
139. Belury M.A. Inhibition of carcinogenesis by conjugated linoleic acid potential mechanisms of action . J Nutr. 132:2002;2995-2998.
140. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages evidence for a PPAR gamma-dependent mechanism . Biochim Biophys Acta. 1581:2002;89-99.
141. Park Y., Allen K.G., Shultz T.D. Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res. 20:2000;669-676.
142. Jump D.B., Ren B., Clarke S., Thelen A. Effects of fatty acids on hepatic gene expression. Prostaglandins Leukot Essent Fatty Acids. 52:1995;107-111.